NCT07288359
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07288359
Title Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | ESP | DNK | DEU

Facility Status City State Zip Country Details
Tennessee Oncology PLLC RECRUITING Nashville Tennessee 37203 United States Details
Novartis Investigative Site RECRUITING Odense C 5000 Denmark Details
Novartis Investigative Site RECRUITING Jena Thuringia 07740 Germany Details
Novartis Investigative Site RECRUITING Essen 45147 Germany Details
Novartis Investigative Site RECRUITING Milan MI 20162 Italy Details
Novartis Investigative Site RECRUITING Milan 20141 Italy Details
Novartis Investigative Site RECRUITING Kyoto 6068507 Japan Details
Novartis Investigative Site RECRUITING Singapore 168583 Singapore Details
Novartis Investigative Site RECRUITING Barcelona 08035 Spain Details
Novartis Investigative Site RECRUITING Madrid 28041 Spain Details
Novartis Investigative Site RECRUITING Taipei 10002 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field